Latest News and Press Releases
Want to stay updated on the latest news?
-
SEATTLE, WA--(Marketwired - Apr 23, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, believes that new recommendations published on April 16 by the U.S. Preventative...
-
SEATTLE, WA--(Marketwired - Apr 23, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, announced today that Kyle Guse, CFO and General Counsel, will present the...
-
SEATTLE, WA--(Marketwired - Apr 16, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, will soon begin providing its patented ForeCYTE Breast Health Test for early...
-
SEATTLE, WA--(Marketwired - Apr 15, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, today announced the launch of a new National Awareness Program, including a video...
-
SEATTLE, WA--(Marketwire - Mar 13, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, has entered into a contractual agreement with FedMed, Inc., one of the largest...
-
SEATTLE, WA--(Marketwire - Mar 6, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, announced today that Steven C. Quay, M.D., Ph.D., FCAP, chairman, CEO &...
-
SEATTLE, WA--(Marketwire - Feb 5, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, announced today that Kyle Guse, CFO and General Counsel, will present...
-
SEATTLE, WA--(Marketwire - Feb 4, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS) announced that its new ForeCYTE Breast Health System addresses the problem of detecting not only cancer,...
-
SEATTLE, WA--(Marketwire - Jan 28, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, announced today that Dr. Steven C. Quay, M.D., Ph.D., FCAP, Chairman, CEO and...
-
SEATTLE, WA--(Marketwire - Jan 18, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS) announced today that Kyle Guse, chief financial officer, general counsel and secretary, will present at the NINE...